Access Health Renewal | |
174 So. Freeport Road Suite 2a Freeport ME 04032 | |
(207) 865-5520 | |
(866) 270-1070 |
Full Name | Access Health Renewal |
---|---|
Speciality | Clinic/center |
Location | 174 So. Freeport Road, Freeport, Maine |
Authorized Official Name and Position | Ariel E. Wilcox (PRESIDENT) |
Authorized Official Contact | 2078655520 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Access Health Renewal 174 So. Freeport Road Suite 2a Freeport ME 04032 Ph: (207) 865-5520 | Access Health Renewal 174 So. Freeport Road Suite 2a Freeport ME 04032 Ph: (207) 865-5520 |
NPI Number | 1609137843 |
---|---|
Provider Enumeration Date | 06/05/2012 |
Last Update Date | 06/06/2012 |
Identifier | Type | State | Issuer |
---|---|---|---|
1609137843 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
An integrative approach to treating chronic pain significantly reduces pain severity while improving mood and quality of life, according to a new study from the Bravewell Practice-Based Research Network (BraveNet) published last month in BioMed Central Complementary and Alternative Medicine journal.
Neurologix, Inc., a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September 30, 2009.
The Joint Center for Cancer Precision Medicine, a collaborative initiative among Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston Children's Hospital, and the Broad Institute of MIT and Harvard, has been established to create "precision medicine treatment pathways" for patients with advanced cancers and to speed the development of personalized therapies.
A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.
The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) and the U.S. Food and Drug Administration (FDA) has launched an initiative to help ensure the safe use of methadone.
› Verified 8 days ago
Be Well My Friend Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 174 S Freeport Rd, Suite 2a, Freeport, ME 04032 Phone: 855-239-3556 Fax: 207-512-5909 | |
Complete Reimbursement Services, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 21 Renee Rd, Freeport, ME 04032 Phone: 917-603-2684 | |
Southern Maine Geriatrics Associates Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 50 Marquis Rd, Freeport, ME 04032 Phone: 207-865-6131 Fax: 207-865-9399 | |
Freeport Family Health Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 174 S Freeport Rd, Freeport, ME 04032 Phone: 207-865-6113 |